27-Hydroxycholesterol enhanced osteoclastogenesis in lung adenocarcinoma microenvironment.

Area of Science:

• Oncology
• Molecular Biology
• Biochemistry

Background:

• 27-Hydroxycholesterol (27-HC) is linked to estrogen receptor-positive breast cancer.
• The role of 27-HC in lung adenocarcinoma, particularly in bone metastasis, remains largely unknown.
• Bone metastasis significantly contributes to lung adenocarcinoma mortality.

Purpose of the Study:

• To investigate the impact of 27-HC on osteoclastogenesis within the lung adenocarcinoma microenvironment.
• To elucidate the molecular mechanisms by which 27-HC influences osteoclast differentiation in this context.

Main Methods:

• Co-culture of lung adenocarcinoma cells with macrophages to generate conditioned media (CM).
• Analysis of miR-139, c-Fos, NFATc1, and STAT3 expression and activity.
• Luciferase reporter assays, co-immunoprecipitation, and chromatin immunoprecipitation assays.
• Experimental manipulation including 27-HC treatment and c-Fos knockdown.

Main Results:

• CM from lung adenocarcinoma cells promoted osteoclast differentiation, an effect amplified by 27-HC.
• CM inhibited miR-139 and promoted c-Fos expression; c-Fos is a direct target of miR-139.
• 27-HC enhanced the expression and nuclear translocation of NFATc1 and STAT3 phosphorylation.
• 27-HC increased interactions between NFATc1 and pSTAT3, and promoted STAT3/c-Fos/NFATc1 pathway activation, leading to increased osteoclastogenesis.

Conclusions:

• 27-HC significantly promotes osteoclastogenesis in the lung adenocarcinoma microenvironment.
• The mechanism involves 27-HC-mediated inhibition of miR-139 and subsequent activation of the STAT3/c-Fos/NFATc1 signaling pathway.
• These findings highlight 27-HC as a potential therapeutic target for mitigating bone metastasis in lung adenocarcinoma.